Memories of 1982 are still fresh in Mr Church's mind, especially as he has been trying to "build upsomeexcitement" for the coming day among his younger children.
Schroer's fund, invested largely in pharmaceuticals and biotech, is up 35% so far this year on the strength of some good venture-capital investments and investor excitement over the potential genomic revolution.